Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
HealthcareAdd-on
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Servier Pharmaceuticals LLC and Servier Detroit Inc. entered into an agreement and plan of merger with Day One Biopharmaceuticals, Inc., dated March 6, 2026.
The filing is an exhibit to a company SEC 8-K and includes merger mechanics such as an offer process, merger closing provisions, and effects on capital stock. It also outlines conditions precedent, termination provisions, and covenants relating to conduct of business and no solicitation.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026